APO Research
Talk to an analyst

APO RESEARCH · REPORT

Micafungin Sodium Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Micafungin Sodium Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026188 pages

Choose your research edition.

Industry ResearchMicafungin Sodium Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Micafungin Sodium Drug Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Micafungin Sodium Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Micafungin Sodium Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Micafungin Sodium Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Micafungin Sodium Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Micafungin Sodium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Micafungin Sodium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Micafungin Sodium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Micafungin Sodium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Micafungin Sodium Drug include Apotex, Endo International, Hikma, Xellia Pharmaceuticals, Astellas, Jiangsu Hansoh Pharmaceutical and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Micafungin Sodium Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Micafungin Sodium Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Micafungin Sodium Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Micafungin Sodium Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Micafungin Sodium Drug Segment by Company

Apotex

Endo International

Hikma

Xellia Pharmaceuticals

Astellas

Jiangsu Hansoh Pharmaceutical

Teva

Micafungin Sodium Drug Segment by Type

50 mg Single-use Vial

100 mg Single-use Vial

Micafungin Sodium Drug Segment by Application

Respiratory Mycosis

Candidemia

Gastrointestinal Mycosis

Micafungin Sodium Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Micafungin Sodium Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Micafungin Sodium Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Micafungin Sodium Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Micafungin Sodium Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Micafungin Sodium Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Micafungin Sodium Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Micafungin Sodium Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Micafungin Sodium Drug Industry Trends Table 2. Micafungin Sodium Drug Industry Drivers Table 3. Micafungin Sodium Drug Industry Opportunities and Challenges Table 4. Micafungin Sodium Drug Industry Restraints Table 5. Global Micafungin Sodium Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Micafungin Sodium Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Micafungin Sodium Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Micafungin Sodium Drug Sales Market Share by Manufacturers Table 9. Global Micafungin Sodium Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Micafungin Sodium Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Micafungin Sodium Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Micafungin Sodium Drug Manufacturers, Product Type & Application Table 13. Global Micafungin Sodium Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Micafungin Sodium Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50 mg Single-use Vial Table 17. Major Manufacturers of 100 mg Single-use Vial Table 18. Global Micafungin Sodium Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Micafungin Sodium Drug Sales by Type (2021-2026) & (K Units) Table 20. Global Micafungin Sodium Drug Sales by Type (2027-2032) & (K Units) Table 21. Global Micafungin Sodium Drug Sales Market Share by Type (2021-2026) Table 22. Global Micafungin Sodium Drug Sales Market Share by Type (2027-2032) Table 23. Global Micafungin Sodium Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Micafungin Sodium Drug Revenue by Type (2021-2026) & (K Units) Table 25. Global Micafungin Sodium Drug Revenue by Type (2027-2032) & (K Units) Table 26. Global Micafungin Sodium Drug Revenue Market Share by Type (2021-2026) Table 27. Global Micafungin Sodium Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Respiratory Mycosis Table 29. Major Manufacturers of Candidemia Table 30. Major Manufacturers of Gastrointestinal Mycosis Table 31. Global Micafungin Sodium Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Micafungin Sodium Drug Sales by Application (2021-2026) & (K Units) Table 33. Global Micafungin Sodium Drug Sales by Application (2027-2032) & (K Units) Table 34. Global Micafungin Sodium Drug Sales Market Share by Application (2021-2026) Table 35. Global Micafungin Sodium Drug Sales Market Share by Application (2027-2032) Table 36. Global Micafungin Sodium Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Micafungin Sodium Drug Revenue by Application (2021-2026) & (K Units) Table 38. Global Micafungin Sodium Drug Revenue by Application (2027-2032) & (K Units) Table 39. Global Micafungin Sodium Drug Revenue Market Share by Application (2021-2026) Table 40. Global Micafungin Sodium Drug Revenue Market Share by Application (2027-2032) Table 41. Global Micafungin Sodium Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Micafungin Sodium Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Micafungin Sodium Drug Sales Market Share by Region (2021-2026) Table 44. Global Micafungin Sodium Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Micafungin Sodium Drug Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Micafungin Sodium Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Micafungin Sodium Drug Sales by Country (2021-2026) & (K Units) Table 48. North America Micafungin Sodium Drug Sales by Country (2027-2032) & (K Units) Table 49. Europe Micafungin Sodium Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Micafungin Sodium Drug Sales by Country (2021-2026) & (K Units) Table 51. Europe Micafungin Sodium Drug Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Micafungin Sodium Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Micafungin Sodium Drug Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Micafungin Sodium Drug Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Micafungin Sodium Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Micafungin Sodium Drug Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Micafungin Sodium Drug Sales by Country (2027-2032) & (K Units) Table 58. Global Micafungin Sodium Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Micafungin Sodium Drug Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Micafungin Sodium Drug Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Micafungin Sodium Drug Revenue Market Share by Region (2021-2026) Table 62. Global Micafungin Sodium Drug Revenue Market Share by Region (2027-2032) Table 63. Apotex Company Information Table 64. Apotex Business Overview Table 65. Apotex Micafungin Sodium Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Apotex Micafungin Sodium Drug Product Portfolio Table 67. Apotex Recent Development Table 68. Endo International Company Information Table 69. Endo International Business Overview Table 70. Endo International Micafungin Sodium Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Endo International Micafungin Sodium Drug Product Portfolio Table 72. Endo International Recent Development Table 73. Hikma Company Information Table 74. Hikma Business Overview Table 75. Hikma Micafungin Sodium Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Hikma Micafungin Sodium Drug Product Portfolio Table 77. Hikma Recent Development Table 78. Xellia Pharmaceuticals Company Information Table 79. Xellia Pharmaceuticals Business Overview Table 80. Xellia Pharmaceuticals Micafungin Sodium Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Xellia Pharmaceuticals Micafungin Sodium Drug Product Portfolio Table 82. Xellia Pharmaceuticals Recent Development Table 83. Astellas Company Information Table 84. Astellas Business Overview Table 85. Astellas Micafungin Sodium Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Astellas Micafungin Sodium Drug Product Portfolio Table 87. Astellas Recent Development Table 88. Jiangsu Hansoh Pharmaceutical Company Information Table 89. Jiangsu Hansoh Pharmaceutical Business Overview Table 90. Jiangsu Hansoh Pharmaceutical Micafungin Sodium Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Jiangsu Hansoh Pharmaceutical Micafungin Sodium Drug Product Portfolio Table 92. Jiangsu Hansoh Pharmaceutical Recent Development Table 93. Teva Company Information Table 94. Teva Business Overview Table 95. Teva Micafungin Sodium Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Teva Micafungin Sodium Drug Product Portfolio Table 97. Teva Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Micafungin Sodium Drug Distributors List Table 101. Micafungin Sodium Drug Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Micafungin Sodium Drug Product Image Figure 2. Global Micafungin Sodium Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Micafungin Sodium Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Micafungin Sodium Drug Sales (2021-2032) & (K Units) Figure 5. Global Micafungin Sodium Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Micafungin Sodium Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50 mg Single-use Vial Image Figure 9. 100 mg Single-use Vial Image Figure 10. Global Micafungin Sodium Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Micafungin Sodium Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Micafungin Sodium Drug Sales Market Share by Type (2021-2032) Figure 13. Global Micafungin Sodium Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Micafungin Sodium Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Micafungin Sodium Drug Revenue Market Share by Type (2021-2032) Figure 16. Respiratory Mycosis Image Figure 17. Candidemia Image Figure 18. Gastrointestinal Mycosis Image Figure 19. Global Micafungin Sodium Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Micafungin Sodium Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Micafungin Sodium Drug Sales Market Share by Application (2021-2032) Figure 22. Global Micafungin Sodium Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Micafungin Sodium Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Micafungin Sodium Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Micafungin Sodium Drug Sales Market Share by Country (2021-2032) Figure 27. U.S. Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Micafungin Sodium Drug Sales Market Share by Country (2021-2032) Figure 32. Germany Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Micafungin Sodium Drug Sales Market Share by Country (2021-2032) Figure 39. China Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Micafungin Sodium Drug Sales Market Share by Country (2021-2032) Figure 47. Brazil Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Micafungin Sodium Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Micafungin Sodium Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Micafungin Sodium Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Micafungin Sodium Drug Revenue (2021-2032) & (US$ Million) Figure 58. North America Micafungin Sodium Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Micafungin Sodium Drug Revenue (2021-2032) & (US$ Million) Figure 60. Europe Micafungin Sodium Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Micafungin Sodium Drug Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Micafungin Sodium Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Micafungin Sodium Drug Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Micafungin Sodium Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Micafungin Sodium Drug Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Micafungin Sodium Drug Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mg Single-use Vial
  • 100 mg Single-use Vial
Applications
  • Respiratory Mycosis
  • Candidemia
  • Gastrointestinal Mycosis
Companies covered
  • Apotex
  • Endo International
  • Hikma
  • Xellia Pharmaceuticals
  • Astellas
  • Jiangsu Hansoh Pharmaceutical
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Micafungin Sodium Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Micafungin Sodium Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Micafungin Sodium Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Micafungin Sodium Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Micafungin Sodium Drug Market Dynamics
  1. 2.1 Micafungin Sodium Drug Industry Trends
  2. 2.2 Micafungin Sodium Drug Industry Drivers
  3. 2.3 Micafungin Sodium Drug Industry Opportunities and Challenges
  4. 2.4 Micafungin Sodium Drug Industry Restraints
3 Micafungin Sodium Drug Market by Manufacturers
  1. 3.1 Global Micafungin Sodium Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Micafungin Sodium Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Micafungin Sodium Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Micafungin Sodium Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Micafungin Sodium Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Micafungin Sodium Drug Manufacturers, Product Type & Application
  7. 3.7 Global Micafungin Sodium Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Micafungin Sodium Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Micafungin Sodium Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Micafungin Sodium Drug Tier 1, Tier 2, and Tier 3
4 Micafungin Sodium Drug Market by Type
  1. 4.1 Micafungin Sodium Drug Type Introduction
  2. 4.1.1 50 mg Single-use Vial
  3. 4.1.2 100 mg Single-use Vial
  4. 4.2 Global Micafungin Sodium Drug Sales by Type
  5. 4.2.1 Global Micafungin Sodium Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Micafungin Sodium Drug Sales by Type (2021-2032)
  7. 4.2.3 Global Micafungin Sodium Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global Micafungin Sodium Drug Revenue by Type
  9. 4.3.1 Global Micafungin Sodium Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Micafungin Sodium Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global Micafungin Sodium Drug Revenue Market Share by Type (2021-2032)
5 Micafungin Sodium Drug Market by Application
  1. 5.1 Micafungin Sodium Drug Application Introduction
  2. 5.1.1 Respiratory Mycosis
  3. 5.1.2 Candidemia
  4. 5.1.3 Gastrointestinal Mycosis
  5. 5.2 Global Micafungin Sodium Drug Sales by Application
  6. 5.2.1 Global Micafungin Sodium Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Micafungin Sodium Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Micafungin Sodium Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Micafungin Sodium Drug Revenue by Application
  10. 5.3.1 Global Micafungin Sodium Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Micafungin Sodium Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Micafungin Sodium Drug Revenue Market Share by Application (2021-2032)
6 Global Micafungin Sodium Drug Sales by Region
  1. 6.1 Global Micafungin Sodium Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Micafungin Sodium Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Micafungin Sodium Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Micafungin Sodium Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Micafungin Sodium Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Micafungin Sodium Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Micafungin Sodium Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Micafungin Sodium Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Micafungin Sodium Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Micafungin Sodium Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Micafungin Sodium Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Micafungin Sodium Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Micafungin Sodium Drug Revenue by Region
  1. 7.1 Global Micafungin Sodium Drug Revenue by Region
  2. 7.1.1 Global Micafungin Sodium Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Micafungin Sodium Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Micafungin Sodium Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Micafungin Sodium Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Micafungin Sodium Drug Revenue (2021-2032)
  8. 7.2.2 North America Micafungin Sodium Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Micafungin Sodium Drug Revenue (2021-2032)
  11. 7.3.2 Europe Micafungin Sodium Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Micafungin Sodium Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Micafungin Sodium Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Micafungin Sodium Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Micafungin Sodium Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Apotex
  2. 8.1.1 Apotex Company Information
  3. 8.1.2 Apotex Business Overview
  4. 8.1.3 Apotex Micafungin Sodium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Apotex Micafungin Sodium Drug Product Portfolio
  6. 8.1.5 Apotex Recent Developments
  7. 8.2 Endo International
  8. 8.2.1 Endo International Company Information
  9. 8.2.2 Endo International Business Overview
  10. 8.2.3 Endo International Micafungin Sodium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Endo International Micafungin Sodium Drug Product Portfolio
  12. 8.2.5 Endo International Recent Developments
  13. 8.3 Hikma
  14. 8.3.1 Hikma Company Information
  15. 8.3.2 Hikma Business Overview
  16. 8.3.3 Hikma Micafungin Sodium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hikma Micafungin Sodium Drug Product Portfolio
  18. 8.3.5 Hikma Recent Developments
  19. 8.4 Xellia Pharmaceuticals
  20. 8.4.1 Xellia Pharmaceuticals Company Information
  21. 8.4.2 Xellia Pharmaceuticals Business Overview
  22. 8.4.3 Xellia Pharmaceuticals Micafungin Sodium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Xellia Pharmaceuticals Micafungin Sodium Drug Product Portfolio
  24. 8.4.5 Xellia Pharmaceuticals Recent Developments
  25. 8.5 Astellas
  26. 8.5.1 Astellas Company Information
  27. 8.5.2 Astellas Business Overview
  28. 8.5.3 Astellas Micafungin Sodium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Astellas Micafungin Sodium Drug Product Portfolio
  30. 8.5.5 Astellas Recent Developments
  31. 8.6 Jiangsu Hansoh Pharmaceutical
  32. 8.6.1 Jiangsu Hansoh Pharmaceutical Company Information
  33. 8.6.2 Jiangsu Hansoh Pharmaceutical Business Overview
  34. 8.6.3 Jiangsu Hansoh Pharmaceutical Micafungin Sodium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Hansoh Pharmaceutical Micafungin Sodium Drug Product Portfolio
  36. 8.6.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  37. 8.7 Teva
  38. 8.7.1 Teva Company Information
  39. 8.7.2 Teva Business Overview
  40. 8.7.3 Teva Micafungin Sodium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Teva Micafungin Sodium Drug Product Portfolio
  42. 8.7.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Micafungin Sodium Drug Value Chain Analysis
  2. 9.1.1 Micafungin Sodium Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Micafungin Sodium Drug Production Mode & Process
  6. 9.2 Micafungin Sodium Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Micafungin Sodium Drug Distributors
  9. 9.2.3 Micafungin Sodium Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst